NHS Trusts Performance 2025-10-21
2025-10-21
TAGS
Response quality
Questions & Answers
Q1
Partial Answer
▸
Context
In Telford and wider Shropshire, the NHS has a significant backlog due to years of underperformance. The MP mentions falling waiting times and increased government investment in recent months.
Given that Telford and wider Shropshire face an enormous challenge after years of underperformance, how will the Secretary of State ensure trusts showing signs of improvement receive backing to continue their progress, especially with investment in technology, research, and infrastructure?
Absolutely. My hon. Friend deserves real credit for championing Telford and Shropshire and helping to get the trust the investment it needs. We will not turn a blind eye to past failures; we are taking action. Already, we have delivered an extra 94,000 appointments and cut waiting lists by over 14,000 at his local trust since the general election.
▸
Assessment & feedback
Specific commitment to infrastructure investment was not addressed
Response accuracy
Q2
Partial Answer
▸
Context
Homerton University Hospital in Hackney has increased productivity by over 11%, setting an example for other hospitals.
Given the impressive performance of Homerton University Hospital, what specific measures will be taken to support such leaders and ensure they have sufficient funding to sustain their progress?
I was delighted to meet my hon. Friend only recently to hear about the really impressive productivity gains being made at her local trust. We need to incentivise and reward leaders for that kind of outstanding performance and we also need to get some of that best practice to some of our poorest performing trusts.
▸
Assessment & feedback
No specific measures or funding details provided
Response accuracy
Q3
Partial Answer
▸
Context
Oxford University Hospitals Trust does not provide givinostat through the early access programme, affecting a constituent's child who needs it.
Will the Secretary of State meet me, Duchenne UK, and the all-party parliamentary group on access to medicines and medical devices to discuss lessons learned from the early access programme?
I have had the privilege of meeting some of the campaigners, and particularly the young people affected by that cruel condition, and I understand the hon. Gentleman’s frustrations. The medication is being put through the National Institute for Health and Care Excellence process, and I hope that that will deliver a positive outcome.
▸
Assessment & feedback
No commitment to meeting or schedule
Response accuracy